EMERALD RESOURCES NL (EMR)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

EMR - EMERALD RESOURCES NL

FNArena Sector : Gold & Silver
Year End: June
GICS Industry Group : Materials
Debt/EBITDA: N/A
Index: ASX200 | ASX300 | ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$3.62

22 Apr
2024

-0.020

OPEN

$3.69

-0.55%

HIGH

$3.73

1,369,200

LOW

$3.60

OTHER COMPANIES IN THE SAME SECTOR
A1M . ADT . ALK . AMI . BC8 . BEZ . BGL . CAI . CEL . CMM . CNB . CVV . CYL . DEG . EVN . EVR . FFM . FFM . FND . GMD . GOR . GPR . HGO . IGO . KCN . KGL . MAU . MEI . MZZ . NEM . NST . NVA . OBM . ORR . PDI . PNR . PRU . RED . RMS . RRL . RSG . RXL . SBM . SLR . SPR . SSR . STM . STN . SVL . TBR . TIE . TTM . WAF . WGX .
FNARENA'S MARKET CONSENSUS FORECASTS

- No Record -

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx12.1
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx297.7 M
Book Value Per Share xxxxxxxxxxxxxxx53.8
Net Operating Cash Flow xxxxxxxxxxxxxxx64.2 M
Net Profit Margin xxxxxxxxxxxxxxx24.14 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx25.45 %
Return on Invested Capital xxxxxxxxxxxxxxx21.58 %
Return on Assets xxxxxxxxxxxxxxx15.32 %
Return on Equity xxxxxxxxxxxxxxx25.45 %
Return on Total Capital xxxxxxxxxxxxxxx28.32 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx55.6 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx37 M
Long Term Debt xxxxxxxxxxxxxxx43 M
Total Debt xxxxxxxxxxxxxxx80 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx71 M
Price To Book Value xxxxxxxxxxxxxxx3.81

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx8.6 M
Capex % of Sales xxxxxxxxxxxxxxx2.89 %
Cost of Goods Sold xxxxxxxxxxxxxxx183 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx9 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx-

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

0
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

EMR STOCK CHART